BioMarin Pharmaceutical, Inc. (BMRN) — Hedge Fund Ownership Q1 2026
BMRN
- BioMarin Pharmaceutical, Inc. (BMRN) is held by 3 of 82 tracked hedge funds, with Viking Global Investors (1%) and Torray Investment Partners (1%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in BMRN holdings came from Viking Global Investors (+17%), highlighting conviction.
- The biggest decreases in BMRN holdings came from Dodge & Cox (-0.1%), suggesting profit-taking or de-risking.
- Overall, hedge funds increased exposure to BioMarin Pharmaceutical, Inc. (BMRN) by +5% vs the prior quarter and -16% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Viking Global Investors Andreas Halvorsen
|
1.12% | 7.1M | +16.98% | -34.61% | $398.9M | $56.49 | — |
| 2 |
Torray Investment Partners Robert Torray
|
0.65% | 78K | NEW | — | $4.4M | $56.49 | — |
| 3 |
Dodge & Cox
|
0.45% | 14.6M | -0.07% | -2.63% | $822.6M | $56.49 | — |
| 3 | Total | — | 21.7M | +4.92% | -16.04% | $1.23B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.